CIPA Life Sciences: How to navigate the EPO boards of appeal


The European Patent Office boards of appeal are unlikely to be able to reduce the case backlog anytime soon, but attorneys should be wary of possible changes in board practice, former board head Alec Clelland told the Chartered Institute of Patent Attorneys (CIPA) Life Sciences conference.

CIPA Life Sciences conference, EPO boards of appeal, European Patent Office, Alec Clelland